Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 1
2011 1
2012 3
2013 3
2014 3
2015 2
2016 3
2017 1
2018 3
2019 3
2021 2
2022 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

24 results

Results by year

Filters applied: . Clear all
Page 1
Cancer Immune Checkpoint Inhibitor Therapy and the Gut Microbiota.
Frankel AE, Deshmukh S, Reddy A, Lightcap J, Hayes M, McClellan S, Singh S, Rabideau B, Glover TG, Roberts B, Koh AY. Frankel AE, et al. Among authors: mcclellan s. Integr Cancer Ther. 2019 Jan-Dec;18:1534735419846379. doi: 10.1177/1534735419846379. Integr Cancer Ther. 2019. PMID: 31014119 Free PMC article. Review.
Biphasic Postnatal Umbilical Cord Shortening.
Manci EA, Alvarez SS, McClellan SB, Campbell PM, Dasaraju S, Winkler CL, Shah AK. Manci EA, et al. Among authors: mcclellan sb. Pediatr Dev Pathol. 2021 Mar-Apr;24(2):116-120. doi: 10.1177/1093526620984258. Epub 2021 Jan 13. Pediatr Dev Pathol. 2021. PMID: 33439109
PMS2 variant results in loss of ATPase activity without compromising mismatch repair.
D'Arcy BM, Arrington J, Weisman J, McClellan SB, Vandana, Yang Z, Deivanayagam C, Blount J, Prakash A. D'Arcy BM, et al. Among authors: mcclellan sb. Mol Genet Genomic Med. 2022 Feb 21;10(5):e1908. doi: 10.1002/mgg3.1908. Online ahead of print. Mol Genet Genomic Med. 2022. PMID: 35189042 Free PMC article.
Phosphodiesterase 10A (PDE10A) as a novel target to suppress β-catenin and RAS signaling in epithelial ovarian cancer.
Borneman RM, Gavin E, Musiyenko A, Richter W, Lee KJ, Crossman DK, Andrews JF, Wilhite AM, McClellan S, Aragon I, Ward AB, Chen X, Keeton AB, Berry K, Piazza GA, Scalici JM, da Silva LM. Borneman RM, et al. Among authors: mcclellan s. J Ovarian Res. 2022 Nov 2;15(1):120. doi: 10.1186/s13048-022-01050-9. J Ovarian Res. 2022. PMID: 36324187 Free PMC article.
24 results